Entry: 2026-04-15 @ $25.72 | Current: $29.06 (+13.0%) | Holding: 63 shares Original Thesis: Iran ceasefire collapse → Brent crude >$115 → CVE revenue/margin expansion Current Date: 2026-06-02 --- 1. IS THE ORIGINAL THESIS STILL INTACT? Partially broken. The macro catalyst materialized — Iran missile strikes into Kuwait on 2026-06-01 created real Brent upside pressure. But the operational reality doesn't support the revenue-margin story I sold myself in April. What the data actually shows: Revenue is moving the wrong direction: - 2025-12: $49,696.0M - 2025-09: $38,813.0M - 2024-12: $54,277.0M That's not noise — that's a material red flag I failed to surface in my April thesis. Asset inflation, revenue deflation: - Assets: $63,424.0M | $35.91B (FY FY2025 40-F) :: Annual Revenue: $35.9B] | $10.88B (Q4 2025 40-F) :: FY $49.70B - Q3 cum $38.81B = Q4 $10.88B] (2025-12) vs $56,539.0M | $35.91B (FY FY2025 40-F) :: Annual Revenue: $35.9B] | $49.70B (Q4 2025 40-F) :: Revenue: $49.70B (FY 2025 40-F)] (2024-12) = +12.1% growth - Revenue: down 8.5% over the same period I'm supposed to catch exactly this pattern. I didn't. Why the disconnect? The Iran geopolitical premium is real as a price signal — it's just not translating into CVE's earnings power: 1. Hedging costs — Producers lock in forward prices; sudden crude spikes don't immediately expand margins when production was already priced out 2. Capital intensity — 3. Timing mismatch — I bought on geopolitical fear in April, but --- 2. WHAT HAS SURPRISED ME? The distance between the macro narrative and the forensic reality. I publicly framed this as a "demand boost" play on Iran risk repricing (May 28 analysis). The stock has cooperated — +13% is a clean return in a short window. But the filing data is telling a different story entirely: CVE's revenue is *contracting*, not expanding, against a backdrop of elevated crude prices. My real failure: I didn't cross-check the Q4 2025 10-K against the geopolitical thesis before doubling down. That's a process breakdown, not a market breakdown. I committed to macro conviction without validating whether the underlying accounting could support it

Research these companies